ea0046p28 | (1) | UKINETS2016
Partelli Stefano
, Bertani Emilio
, Bartolomei Mirco
, Muffatti Francesca
, Grana Chiara Maria
, Doglioni Claudio
, Fazio Nicola
, Falconi Massimo
Background: Peptide receptor radionuclide therapy (PRRT) can be an option for advanced pancreatic neuroendocrine neoplasms (PNENs) to allow patients undergo resection. Whether or not neoadjuvant PRRT increases postoperative morbidity remains unclear.Methods: Patients with initially metastatic and/or locally advanced PNEN who underwent neoadjuvant PRRT (neoadjuvant group) were compared with a group of patients who underwent upfront surgery (control group)...